β-d-N4-hydroxycytidine, a metabolite of molnupiravir, exhibits in vitro antiviral activity against rabies virus

Rabies is a fatal neurological disorder caused by rabies virus (RABV) infection. Approximately 60,000 patients die from rabies annually, and there are no effective treatments for this disease. Nucleoside analogs are employed as antiviral drugs based on their broad antiviral spectrum, and certain nuc...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Antiviral research 2024-09, Vol.229, p.105977, Article 105977
Hauptverfasser:	Konishi, Kei, Kusakabe, Shinji, Kawaguchi, Nijiho, Shishido, Takao, Ito, Naoto, Harada, Michiko, Inoue, Satoshi, Maeda, Ken, Hall, William W., Orba, Yasuko, Sawa, Hirofumi, Sasaki, Michihito, Sato, Akihiko
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiviral Molnupiravir Nucleoside analog Rabies virus β-d-N4-hydroxycytidine
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!